- Home
- ALT vs BBCP Comparison
ALT vs BBCP Comparison
Compare ALT & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | BBCP |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 333.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALT | BBCP |
|---|---|---|
| Price | $4.54 | $6.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $16.00 | $7.50 |
| AVG Volume (30 Days) | ★ 6.0M | 93.1K |
| Earning Date | 02-26-2026 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $20,000.00 | ★ $392,867,000.00 |
| Revenue This Year | N/A | $1.82 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $68.69 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $4.78 |
| 52 Week High | $7.73 | $9.28 |
Technical Indicators
Market Signals| Indicator | ALT | BBCP |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 32.87 |
| Support Level | $4.03 | $5.95 |
| Resistance Level | $4.40 | $7.72 |
| Average True Range (ATR) | 0.26 | 0.39 |
| MACD | 0.08 | -0.14 |
| Stochastic Oscillator | 99.56 | 2.54 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.